Hogyan lehet hat\u00e9konyan gyeng\u00edteni a feh\u00e9rjehidroliz\u00e1tum keser\u0171 \u00edz\u00e9t?<\/p>\n
A modern \u00e9lelmiszeriparban a feh\u00e9rj\u00e9k hidrol\u00edzise \u00e1ltal\u00e1ban enzimatikus hidrol\u00edzisen alapul, a feh\u00e9rje-hidroliz\u00e1tumok jobb \u00e9lettani aktivit\u00e1ssal rendelkeznek, mint az \u00e9p feh\u00e9rj\u00e9k, \u00e9s a kis molekul\u00e1j\u00fa peptidek k\u00f6nnyen \u00e9s gyorsan felsz\u00edv\u00f3dnak az emberi szervezetben. A leg\u00fajabb vizsg\u00e1latok kimutatt\u00e1k, hogy a hidroliz\u00e1tumok, mint p\u00e9ld\u00e1ul a sz\u00f3jabab peptidek alacsony antigenit\u00e1ssal, v\u00e9rnyom\u00e1scs\u00f6kkent\u0151, koleszterincs\u00f6kkent\u0151 \u00e9s egy\u00e9b eg\u00e9szs\u00e9g\u00fcgyi funkci\u00f3kkal is rendelkeznek. A feh\u00e9rj\u00e9k azonban az enzimatikus hidrol\u00edzis sor\u00e1n k\u00fcl\u00f6nb\u00f6z\u0151 fok\u00fa keser\u0171s\u00e9get okoznak, ami korl\u00e1tozza a feh\u00e9rje-hidroliz\u00e1tumok alkalmaz\u00e1s\u00e1t a modern \u00e9lelmiszerekben. Ez\u00e9rt a feh\u00e9rjehidroliz\u00e1tum keser\u0171 \u00edz\u00e9nek cs\u00f6kkent\u00e9se a f\u0151 technikai sz\u0171k keresztmetszet a feh\u00e9rjehidroliz\u00e1tumok \u00e9lelmiszeripari felhaszn\u00e1l\u00e1s\u00e1nak fejleszt\u00e9s\u00e9ben. Ebben a tanulm\u00e1nyban \u00e1ttekintj\u00fck a keser\u0171 \u00edz kialakul\u00e1s\u00e1t befoly\u00e1sol\u00f3 t\u00e9nyez\u0151ket \u00e9s a keser\u0171 \u00edz elt\u00e1vol\u00edt\u00e1s\u00e1nak m\u00f3dszereit.<\/p>\n
Keser\u0171 \u00edz el\u0151\u00e1ll\u00edt\u00e1sa<\/p>\n
A feh\u00e9rje-hidroliz\u00e1tum keser\u0171 \u00edze els\u0151sorban a hidroliz\u00e1tumban l\u00e9v\u0151 hidrof\u00f3b polipeptidb\u0151l sz\u00e1rmazik, a term\u00e9szetes feh\u00e9rje \u00f6nmag\u00e1ban nem rendelkezik keser\u0171 \u00edzzel, a hidrof\u00f3b oldall\u00e1nc nagy r\u00e9sze a feh\u00e9rjemolekul\u00e1n bel\u00fcl van, amely nem tud kapcsolatba ker\u00fclni az \u00edzlel\u0151sejtekkel; m\u00e1sr\u00e9szt az \u00e9p feh\u00e9rj\u00e9k nagy molekulat\u00f6meggel \u00e9s \u00f6sszetett molekul\u00e1ris konfigur\u00e1ci\u00f3val rendelkeznek, \u00e9s a hidrof\u00f3b marad\u00e9kok \u00e9s az \u00edzlel\u0151bimb\u00f3kon l\u00e9v\u0151 \u00edz\u00e9rz\u00e9kel\u0151k k\u00f6z\u00f6tt t\u00e9rbeli t\u00e1vols\u00e1g van, \u00edgy nem keletkezik keser\u0171 \u00edz. A feh\u00e9rj\u00e9k enzimatikus hidrol\u00edzise ut\u00e1n, amikor kisebb molekulat\u00f6meg\u0171 polipeptidek keletkeznek, a hidrof\u00f3b oldall\u00e1ncok szabadd\u00e1 v\u00e1lnak, \u00e9s a polipeptidek \u00e9rintkez\u00e9sbe ker\u00fclnek az \u00edzlel\u0151sejtekkel, \u00e9s keser\u0171 \u00edzt okoznak. Ezenk\u00edv\u00fcl a peptidben l\u00e9v\u0151 hidrofil csoportok \u00e9s b\u00e1zikus aminosavmarad\u00e9kok jelenl\u00e9te is hat\u00e1ssal van a peptid keser\u0171 \u00edz\u00e9re.<\/p>\n
A keser\u0171 \u00edz kialakul\u00e1s\u00e1nak t\u00e9nyez\u0151i<\/p>\n
A keser\u0171 peptidek hidrofobicit\u00e1sa
\nA peptid aminosav szekvenci\u00e1ja (els\u0151dleges szerkezete)
\nA peptid t\u00e9rbeli szerkezete (m\u00e1sodlagos szerkezet)
\nA peptid molekulat\u00f6meg\u00e9nek m\u00e9rete, a feh\u00e9rje nyersanyag forr\u00e1sa
\nA prote\u00e1z t\u00edpus\u00e1nak kiv\u00e1laszt\u00e1sa
\nA feh\u00e9rje hidrol\u00edzis\u00e9nek m\u00e9rt\u00e9ke<\/p>\n
A prote\u00e1z enzimatikus reakci\u00f3ja sor\u00e1n a prote\u00e1z k\u00fcl\u00f6nb\u00f6z\u0151 helyekr\u0151l a nagy feh\u00e9rjemolekul\u00e1kat sz\u00e9tv\u00e1lasztja, \u00e9s kis polipeptidmolekul\u00e1kk\u00e1 alakulnak. Ha a polipeptid v\u00e9g\u00e9n hidrof\u00f3b aminosavmaradv\u00e1nyok vannak, vagy a polipeptid t\u00f6bb hidrof\u00f3b aminosavat tartalmaz, akkor k\u00f6nnyen \u00f6sszekapcsol\u00f3dik a keser\u0171 receptorral, \u00e9s nagy intenzit\u00e1s\u00fa keser\u0171 \u00edzt eredm\u00e9nyez; \u00e9s meg\u00e1llap\u00edtott\u00e1k, hogy az egyetlen egys\u00e9g form\u00e1j\u00e1ban l\u00e9tez\u0151 hidrof\u00f3b aminosavak keser\u0171 \u00edze sokkal gyeng\u00e9bb. Gyakori hidrof\u00f3b aminosavak a tirozin, triptof\u00e1n, fenilalanin, valin, leucin, izoleucin, alanin \u00e9s metionin [6], ezen aminosavak ar\u00e1ny\u00e1nak cs\u00f6kkent\u00e9se a polipeptid k\u00f6zep\u00e9n \u00e9s v\u00e9g\u00e9n jelent\u0151sen cs\u00f6kkentheti a proteolitikus term\u00e9kek keser\u0171 \u00edz\u00e9t.<\/p>\n
T\u00f6bb \u00e9ves intenz\u00edv kutat\u00e1s ut\u00e1n kifejlesztett\u00fck az FF sorozatot (k\u00e9t term\u00e9kkel: FF104 \u00e9s FF106), egy olyan komplex enzimk\u00e9sz\u00edtm\u00e9nyt, amely jelent\u0151sen cs\u00f6kkenti a proteolitikus em\u00e9szt\u0151anyagok keser\u0171 \u00edz\u00e9t. Az enzimeket kiv\u00e1lasztott endonukle\u00e1zok \u00e9s exonukle\u00e1zok kever\u00e9s\u00e9vel \u00e1ll\u00edtjuk el\u0151. Az endonukle\u00e1z k\u00e9pes hat\u00e9konyan hidroliz\u00e1lni a feh\u00e9rj\u00e9k bels\u0151 peptidl\u00e1nc\u00e1t \u00e9s a nagy feh\u00e9rj\u00e9ket polipeptidekk\u00e9 hidroliz\u00e1lni; az exonukle\u00e1z k\u00e9pes gyorsan lev\u00e1gni a polipeptidl\u00e1nc N-termin\u00e1lis v\u00e9g\u00e9n l\u00e9v\u0151 hidrof\u00f3b aminosavakat \u00e9s az N-termin\u00e1lis v\u00e9g\u00e9n l\u00e9v\u0151 hidrofil aminosavakkal rendelkez\u0151 polipeptidekk\u00e9 alak\u00edtani. Az N-termin\u00e1lis v\u00e9g\u00e9n hidrof\u00f3b aminosavakkal rendelkez\u0151 peptidek ar\u00e1ny\u00e1nak cs\u00f6kkent\u00e9s\u00e9vel a proteolitikus oldat keser\u0171 \u00edze cs\u00f6kkenthet\u0151.<\/p>\n
Jelentkez\u00e9si folyamat<\/p>\n
Proteolitikus oldat --pH6,0-6,5, T 50-55 \u2103-- Adjunk hozz\u00e1 0,1-0,3% FF104\/FF106-- 5-6 \u00f3r\u00e1n \u00e1t reag\u00e1ljunk-- Emelj\u00fck a h\u0151m\u00e9rs\u00e9kletet 75 \u2103-ra, tartsuk melegen 30 percig-- Adjunk hozz\u00e1 m\u00e1s anyagokat, Melad reakci\u00f3 -- Koncentr\u00e1l\u00e1s \u00e9s sz\u00e1r\u00edt\u00e1s -- K\u00e9sz term\u00e9k<\/p>\n
Alkalmaz\u00e1si p\u00e9ld\u00e1k<\/p>\n
FF104 \u00e9s FF106 alkalmaz\u00e1sa \u00e9leszt\u0151kivonatokban<\/p>\n
Mindk\u00e9t enzimk\u00e9sz\u00edtm\u00e9ny jelent\u0151sen jav\u00edthatja a term\u00e9k keser\u0171s\u00e9g\u00e9t, bizonyos fokoz\u00f3 hat\u00e1ssal van a frissess\u00e9gre, a telts\u00e9gre \u00e9s a vastags\u00e1gra, \u00e9s jelent\u0151sen jav\u00edthatja az alkalmazott term\u00e9k \u00e1ltal\u00e1nos \u00edz\u00e9t.<\/p>\n
<\/p>\n
In enzyme and food-processing projects, the most useful decision frame is usually application fit plus process stability: which ingredient performs under the intended pH, temperature, time, and substrate conditions without creating a downstream quality or compliance problem.<\/p>\n
Why is a high-activity enzyme not automatically the best commercial choice?<\/strong> Should food and biotech ingredients be selected from data sheets alone?<\/strong> <\/p>\n <\/p>\n Quick answer:<\/strong> A practical enzyme or food-ingredient decision starts with the process target, then checks activity, application window, sensory impact, and batch-to-batch consistency before scale-up.<\/p>\n <\/p>\n In modern food industry, protein hydrolysis is generally based on enzymatic hydrolysis, protein hydrolysates have better physiological activity than intact proteins, and small molecule peptides are easy to be absorbed<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[108],"tags":[],"class_list":["post-7354","post","type-post","status-publish","format-standard","hentry","category-enzyme-news"],"yoast_head":"\n
Because the best enzyme is the one that performs reliably under the actual process conditions and gives the desired downstream result without creating new issues.<\/p>\n
It is usually safer to pair the specification review with a pilot or application test because real substrates and process windows can change the result a lot.<\/p>\nL\u00e9pjen kapcsolatba vel\u00fcnk most!<\/b><\/strong><\/h2>\n
Ha sz\u00fcks\u00e9ge van Price-ra, k\u00e9rj\u00fck, t\u00f6ltse ki el\u00e9rhet\u0151s\u00e9g\u00e9t az al\u00e1bbi \u0171rlapon, \u00e1ltal\u00e1ban 24 \u00f3r\u00e1n bel\u00fcl felvessz\u00fck \u00d6nnel a kapcsolatot. \u00d6n is k\u00fcldhet nekem e-mailt\u00a0info@longchangchemical.com<\/a><\/span>\u00a0munkaid\u0151ben ( 8:30-18:00 UTC+8 H.-Szombat ) vagy haszn\u00e1lja a weboldal \u00e9l\u0151 chatj\u00e9t, hogy azonnali v\u00e1laszt kapjon.<\/b><\/strong><\/h4>\n
\n\n
\n \u00d6sszet\u00e9tel Gl\u00fckoamil\u00e1z<\/span><\/a><\/td>\n 9032-08-0<\/td>\n<\/tr>\n \n Pullulanase<\/span><\/a><\/td>\n 9075-68-7<\/td>\n<\/tr>\n \n Xilan\u00e1z<\/span><\/a><\/td>\n 37278-89-0<\/td>\n<\/tr>\n \n Cellul\u00e1z<\/span><\/a><\/td>\n 9012-54-8<\/td>\n<\/tr>\n \n Naringin\u00e1z<\/span><\/a><\/td>\n 9068-31-9<\/td>\n<\/tr>\n \n \u03b2-Amil\u00e1z<\/span><\/a><\/td>\n 9000-91-3<\/td>\n<\/tr>\n \n Gl\u00fck\u00f3z-oxid\u00e1z<\/span><\/a><\/td>\n 9001-37-0<\/td>\n<\/tr>\n \n alfa-amil\u00e1z<\/td>\n 9000-90-2<\/td>\n<\/tr>\n \n Pektin\u00e1z<\/span><\/a><\/td>\n 9032-75-1<\/td>\n<\/tr>\n \n Peroxid\u00e1z<\/td>\n 9003-99-0<\/td>\n<\/tr>\n \n Lip\u00e1z<\/span><\/a><\/td>\n 9001-62-1<\/td>\n<\/tr>\n \n Katal\u00e1z<\/span><\/a><\/td>\n 9001-05-2<\/td>\n<\/tr>\n \n TANNASE<\/span><\/a><\/td>\n 9025-71-2<\/td>\n<\/tr>\n \n Elaszt\u00e1z<\/span><\/a><\/td>\n 39445-21-1<\/td>\n<\/tr>\n \n Ure\u00e1z<\/span><\/a><\/td>\n 9002-13-5<\/td>\n<\/tr>\n \n DEXTRANASE<\/span><\/a><\/td>\n 9025-70-1<\/td>\n<\/tr>\n \n L-laktil-dehidrogen\u00e1z<\/span><\/a><\/td>\n 9001-60-9<\/td>\n<\/tr>\n \n Dehidrogen\u00e1z mal\u00e1t<\/span><\/a><\/td>\n 9001-64-3<\/td>\n<\/tr>\n \n Koleszterin-oxid\u00e1z<\/span><\/a><\/td>\n 9028-76-6<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","protected":false},"excerpt":{"rendered":"